Skip to content

Thu 19 Nov 2026

NEInsider
Breaking

Tripura · Health · West Tripura

Tripura cancer drugs: anastrozole strip now Rs 73 as pharmacy checks begin

Tripura's drug regulator says 137 cancer medicines must sell at lower prices from November 9, with some cut by up to 96.45%. Old stock gets no exemption, and Assam is running its own 90-day inspection drive.

By · AI news writer · Published · 5 min read

A strip of 10 anastrozole tablets, a common breast-cancer medicine, should now cost Rs 73 at a Tripura pharmacy instead of Rs 695. The state's drug regulator says this is one of 137 cancer medicines whose maximum retail prices (MRP) were cut from November 9. It has started going shop to shop to make sure patients actually pay the lower price.

Deputy Drugs Controller Subrata Das gave the figures on Wednesday, NorthEast Now and Northeast Today reported. The revision covers about 543 brands and 1,364 formulations, both chemotherapy injections and tablets.

How much cheaper

Das gave three examples. NEInsider worked out the percentage cut for each from the old and new prices he quoted:

| Medicine | Old price | New price | Cut |

|---|---|---|---|

| Anastrozole tablets (strip of 10) | Rs 695 | Rs 73 | about 89% |

| Fludarabine injection, 50 mg | Rs 14,235 | Rs 2,432 | about 83% |

| Fulvestrant injection | over Rs 26,000 | Rs 5,491 | about 79% or more |

According to both reports, many medicines are now 78 to 82 per cent cheaper and the biggest single cut is 96.45 per cent. Das did not say which medicine fell the most. ENewsTime quoted him as saying patients across the country should save about Rs 3,540 crore a year.

Where the cut comes from

The cut is not a Tripura decision. It comes from the National Pharmaceutical Pricing Authority (NPPA) under the Union Ministry of Chemicals and Fertilisers. As NEInsider reported from Assam on November 2, an NPPA gazette notification dated October 17 capped trade margins on these non-scheduled cancer drugs at 30 per cent of MRP. Before that, distributors and retailers could add very large mark-ups.

Before the cap, the NPPA had found average trade mark-ups of about 170 per cent on these drugs, and up to 700 per cent on some. That is why the size of the cut varies so much from brand to brand. Early reports in Assam spoke of cuts "up to 70 per cent". Tripura's regulator now cites brand-level cuts above 90 per cent. Both can be true, because the saving depends on how heavily each brand was marked up.

The old-stock rule

The most important point for patients is about old stock. Das told pharmacies that medicines supplied after November 9 must be sold at the new MRP, even if the shop bought them at the old higher rate. A strip with an old price printed on it does not justify charging that price.

Two states, two ways of enforcing it

| | Assam | Tripura |

|---|---|---|

| Directive reported | November 2 | November 17-18 |

| Enforcement | 90-day inspection drive across the state | Shop visits and posters, starting in Teliamura on November 17 |

| Where | All retailers, stockists, hospital dispensaries | Pharmacies, plus hospital outlets such as AMRIT pharmacies |

| Consumer tool | NPPA grievance system, state DCA | 'Pharma Sahi' app from Tripura's price monitoring unit |

In Teliamura, a team from the Tripura State Pharmaceutical Price Monitoring and Resource Unit visited medicine shops on Tuesday evening and put up posters showing the revised prices, ENewsTime reported. Das said NPPA representatives and the medical superintendent of the cancer hospital are also running awareness drives. Posters and hoardings are planned at major centres including ILS Hospital and the GB cancer hospital in Agartala.

What it means for Tripura's patients

Most cancer patients in Tripura are treated in Agartala, and some travel to Guwahati or Kolkata. For a hormone therapy like anastrozole, often taken for years, the saving runs into thousands of rupees a year.

Das said high prices had forced some patients to stop treatment partway through, NorthEast Now reported. The state is also trying to bring treatment closer to the north of the state. On November 11, NEInsider reported that the government was planning a 50-bed cancer hospital in Kailashahar next to the Unakoti District Hospital. Lower drug prices matter most in a region where, as ICMR data covered by NEInsider on October 31 showed, cancer rates in Mizoram and Arunachal Pradesh are among the highest in India.

What to do if you are overcharged

  • Check the price before you pay. The 'Pharma Sahi' app from the state monitoring unit shows the notified prices, according to Das.
  • Complain. Das urged patients and families to report any pharmacy charging above the new MRP to the Drugs Control Administration. Complaints can also go to the NPPA, which runs a grievance system for overpricing.

The full NPPA orders and price lists are on the NPPA website. Assam's 90-day drive runs until early February. Tripura has not yet said how long its campaign will last or whether it will publish inspection results.

Timeline

  • October 17: NPPA notifies a 30% trade-margin cap on cancer drugs
  • October 31: ICMR data shows the NE's high cancer burden (NEInsider)
  • November 2: Assam orders sellers to apply the new MRP and announces inspections (NEInsider)
  • November 9: New prices take effect
  • November 11: Tripura plans a Kailashahar cancer hospital (NEInsider)
  • November 17-18: Tripura starts pharmacy checks and publishes example prices

Compiled by NEInsider with AI assistance from the sources credited below. How we use AI

Sources and credits. With inputs from NorthEast Now (19 Nov) https://nenow.in/north-east-news/tripura/tripura-prices-of-137-cancer-medicines-cut-by-up-to-96-45-per-cent.html ; Northeast Today (18 Nov) https://northeasttoday.in/northeast/tripura-cancer-drug-prices-slashed-by-up-to-96-45-new-rates-effective-from-november-9/ ; ENewsTime (17 Nov) https://enewstime.in/tripura-news/cancer-medicine-price-awareness-drive-teliamura-110721.html

Share this story

Forward it to your family WhatsApp group. News from home travels fastest there.